Recurrent BV: Why It Keeps Coming Back and What Helps
Extended and suppressive metronidazole, lactic acid gel, biofilm, triggers and when to ask for referral.
Part of the Bacterial Vaginosis condition guide.
Key fact: Around half to two-thirds of women treated for BV have another episode within twelve months — recurrence is the norm rather than a sign that treatment failed or that you did something wrong.
Get BV Treatment Online
Access Doctor provides BV treatment following a GPhC-regulated online consultation with our pharmacist independent prescribers.
Start a BV consultation →What counts as recurrent BV
A single repeat episode is not recurrent BV. The working definition used in UK sexual health practice is three or more confirmed episodes within twelve months. The word confirmed matters: repeated self-diagnosis is unreliable, because BV, thrush and other causes of discharge overlap considerably.
If you have been treating episodes yourself without testing, the first step is not a different antibiotic — it is confirming that what keeps returning is actually BV. Around 60% of women who self-treat vaginal symptoms with over-the-counter thrush products turn out to have something other than thrush. Our guide to telling BV and thrush apart covers how the two differ, and the Canestest self-test checks vaginal pH at home to help point you in the right direction.
3+
Confirmed episodes in 12 months defines recurrent BV
50–70%
Of women have a recurrence within a year of treatment
~3 months
Typical median time to first recurrence after treatment
Diagnosis first. Before moving to extended or suppressive treatment, a prescriber will want the diagnosis confirmed and other causes excluded — including trichomoniasis, chlamydia and gonorrhoea, which can produce similar discharge. Repeatedly treating unconfirmed episodes with antibiotics is how genuinely treatable causes get missed.
Why BV recurs
BV is not an infection you catch and clear in the way a urinary tract infection is. It is a shift in the balance of the vaginal microbiome, from a community dominated by protective lactobacilli to a mixed overgrowth of anaerobic bacteria such as Gardnerella vaginalis. Antibiotics reduce the overgrowth. They do not rebuild what was lost.
Lactobacilli are not restored
Metronidazole suppresses anaerobes but does nothing to repopulate the protective bacteria that keep vaginal pH below 4.5. Until they return, the environment stays permissive.
Biofilm survives the course
BV-associated bacteria form a dense biofilm adherent to the vaginal wall. Antibiotic concentrations that clear free-floating bacteria penetrate biofilm poorly, so a reservoir can persist and reseed.
The trigger is still there
If douching, scented washes, smoking or a consistent exposure has not changed, the same pressure on the microbiome resumes as soon as treatment ends.
Reintroduction from a partner
BV-associated organisms can be exchanged between sexual partners, and untreated reservoirs may contribute to recurrence in monogamous couples.
This is why the frame of “the antibiotic did not work” is usually wrong. In most recurrences the antibiotic worked exactly as expected; the conditions that allowed the imbalance simply reasserted themselves.
Extended and repeat metronidazole courses
For a first recurrence, a standard course is usually repeated: metronidazole 400 mg twice daily for five to seven days. Where episodes are frequent, prescribers may use a longer course — commonly an extended regimen of ten to fourteen days — before considering ongoing suppression.
Two practical points matter more than which regimen you are given. First, complete the full course even after symptoms settle, because stopping early leaves a larger surviving population. Second, observe the alcohol rule for the duration of the course and for 48 hours afterwards; this is covered in full in our guide to how to take metronidazole.
Alcohol and metronidazole. Drinking alcohol during a metronidazole course or within 48 hours of finishing it can cause flushing, severe nausea, vomiting and palpitations. If a long course makes this impractical, tell your prescriber — a vaginal option may suit you better.
If you are having repeated oral courses, it is reasonable to ask whether a topical route would suit you better. Repeated oral metronidazole is more likely to cause nausea, a metallic taste and post-antibiotic thrush than the vaginal alternatives. See metronidazole side effects and warnings for what to expect and how to manage it.
Suppressive vaginal metronidazole gel
The best-established approach for genuinely recurrent BV is suppressive therapy: after an active episode has been treated, vaginal metronidazole 0.75% gel is used twice weekly for three to six months. In practice this means one applicator on two set days each week — for example every Tuesday and Saturday — rather than a nightly course.
1
Treat the active episode first
Suppression is started after a current episode has been cleared, not instead of treating it. Your prescriber will usually confirm the episode has resolved before moving on.
2
Move to twice-weekly gel
One applicator of Zidoval (metronidazole 0.75%) vaginal gel on two fixed days per week. Application technique is the same as for a standard course — see the Zidoval how-to guide.
3
Continue for three to six months
Shorter periods are less likely to produce a durable change. Keep a simple record of any breakthrough symptoms so the review is based on facts rather than recall.
4
Review before stopping
Recurrence rates rise again once suppression stops, so plan the ending with a prescriber rather than simply running out of gel.
What suppression does and does not do. Twice-weekly gel reduces the frequency of episodes while it is being used. It is a control strategy, not a cure, and the benefit largely does not persist after it is stopped. That is a reason to use it deliberately alongside trigger management — not a reason to avoid it.
Lactic acid gel and the VITA trial
Pharmacy lactic acid gels are widely marketed for BV on the logic that restoring an acidic pH restores the environment lactobacilli prefer. The UK VITA randomised controlled trial tested that logic directly in women with recurrent BV, comparing seven days of oral metronidazole against seven days of intravaginal lactic acid gel.
Recurrence rates over follow-up were similar in both arms, but the trial is clear on the main question: lactic acid gel did not match metronidazole for resolving an active episode. It is reasonable to use a lactic acid gel as an adjunct if you find it helps, and some women prefer it for comfort or to avoid repeated antibiotics. It is not an equivalent substitute for treating a confirmed episode. Our guide to BV gels compared, prescription versus over-the-counter looks at the pharmacy options in detail.
Partner treatment: what the 2025 evidence shows
UK practice has long held that treating male partners does not reduce recurrence, and NICE CKS still states that partner treatment is not routinely needed. That position is now under active reconsideration.
In March 2025 the New England Journal of Medicine published an Australian randomised trial in monogamous heterosexual couples. Women received standard first-line treatment; in the intervention arm their male partner concurrently received oral metronidazole 400 mg twice daily plus 2% clindamycin cream applied to penile skin, both for seven days.
| Group | BV recurrence at 12 weeks | Recurrence rate |
|---|---|---|
| Woman treated, partner also treated | 24 of 69 women (35%) | 1.6 per person-year |
| Woman treated only (standard care) | 43 of 68 women (63%) | 4.2 per person-year |
The trial was stopped early by its safety monitoring board because treating the woman alone was clearly inferior. This is a substantial finding, but one trial in one setting does not change UK guidance on its own, and it applies specifically to women in a regular relationship with a single male partner.
Treat this as emerging, not established. Partner treatment is not currently part of routine UK BV management and is not something we prescribe on that basis. If you have recurrent BV and a regular male partner, raise this evidence with your GP or sexual health clinic so the decision is made with your full history in view.
Managing your triggers
Trigger management is the part of recurrent BV care that you control, and it is the part most often skipped. None of it is glamorous, and it works slowly, but it addresses the environment rather than the symptom.
- Stop douching entirely. Douching is the single most consistently identified modifiable risk factor. It strips the vaginal environment of the bacteria you are trying to preserve.
- Drop scented products. Perfumed washes, bubble bath, vaginal deodorants and scented wipes all disturb pH. Plain water externally is sufficient; the vagina is self-cleaning.
- Reconsider smoking. Smoking is associated with a higher risk of BV and of recurrence, probably through effects on the vaginal microbiome.
- Note the pattern around new partners and unprotected sex. Semen is alkaline and can raise vaginal pH; consistent condom use reduces recurrence for some women. Our guide to BV and sex covers this in full.
- Check your contraception. Copper coils have been associated with BV in some women. If episodes began after insertion, it is worth discussing rather than assuming coincidence.
- Keep a short symptom diary. Dates of episodes, treatments used, periods, new partners. Patterns that are invisible month to month become obvious over six.
Why some women are more prone than others
One of the more useful things to understand about recurrent BV is that it is not simply bad luck, and it is not a failure of hygiene. Vaginal microbiomes differ between women in ways that are largely outside personal control.
Researchers group vaginal bacterial communities into a small number of recognisable states. Most are dominated by a single Lactobacillus species, but they are not equivalent. Communities dominated by Lactobacillus crispatus tend to be the most stable and the most resistant to BV. Those dominated by Lactobacillus iners are markedly less stable, and shift towards a BV-type community much more readily. A further group is diverse from the outset, with low lactobacilli, and sits closest to BV even without symptoms.
The stable type
L. crispatus-dominant communities produce more lactic acid, hold pH lower, and are the least likely to tip into BV.
The unstable type
L. iners-dominant communities are common and much more changeable, which helps explain why some women recur repeatedly on the same treatment.
The diverse type
Low-lactobacilli communities that resemble BV even when asymptomatic, and return to that state quickly after treatment.
Not equally distributed
These community types vary across populations, which is part of why BV prevalence differs between ethnic groups — a biological finding, not a behavioural one.
Why this is worth knowing. It reframes recurrence honestly. If your baseline community is one of the less stable types, antibiotics will keep clearing episodes without changing what you return to. That is an argument for suppressive therapy and sustained trigger management — and against blaming yourself for a pattern you did not cause. Testing to identify your community type is currently a research tool rather than something available through the NHS.
What to ask your clinician
Recurrent BV appointments are often short, and it is easy to leave with another standard course and no plan. These are the questions that tend to change the outcome.
- “Can we confirm the diagnosis on microscopy rather than treating on symptoms?” Repeated empirical treatment is how other causes get missed.
- “Have I been screened for trichomoniasis, chlamydia and gonorrhoea?” These can mimic BV and are frequently not tested when a BV diagnosis feels obvious.
- “Would an extended course be more appropriate than another standard one?” Ten to fourteen days is a recognised step before suppression.
- “Am I a candidate for suppressive twice-weekly vaginal gel?” This is the best-established approach for genuine recurrence and is often not offered unless asked for.
- “Should I switch from oral to vaginal treatment?” Particularly relevant if you have had several oral courses and post-antibiotic thrush each time.
- “Does my contraception need reviewing?” Worth raising if episodes began after a copper coil was fitted.
- “Is referral to a sexual health service appropriate now?” They can do same-day microscopy that primary care usually cannot.
Bring your symptom diary. Dates of episodes, which treatment was used each time, whether it resolved, and how long the symptom-free gap was. Six months of that turns a vague account into something a clinician can act on — and it distinguishes recurrence from treatment failure, which are managed differently.
Order BV Treatment for Recurrent Episodes
Complete a short online consultation and our GPhC-registered pharmacist independent prescribers will assess whether oral or vaginal treatment is appropriate for you.
Start a BV consultation →When to seek specialist referral
Online treatment is appropriate for straightforward, confirmed episodes. Recurrent BV that is not settling needs an in-person assessment.
Seek same-day medical attention if you develop pelvic or lower abdominal pain, fever, pain during sex, bleeding between periods or after sex, or if you are pregnant and develop new discharge with pain. These are not features of uncomplicated BV and need examination. In an emergency, call 999.
Ask your GP for referral to a sexual health or gynaecology service if any of the following apply:
- Three or more confirmed episodes in twelve months
- Episodes that do not respond to a full first-line course
- Uncertainty about the diagnosis, or symptoms that do not fit BV
- Recurrent episodes during pregnancy
- Recurrence continuing despite a completed course of suppressive therapy
Sexual health clinics can perform microscopy on the day, exclude other infections properly and access management options not available in primary care. Being referred is not an escalation of seriousness — it is how a stubborn pattern gets characterised properly.
Frequently Asked Questions
What counts as recurrent BV?
Recurrent BV is usually defined as three or more confirmed episodes in a 12-month period. One repeat episode is common and does not meet the definition — it is the pattern of repeated confirmed episodes that changes how treatment is approached.
Why does my BV keep coming back after antibiotics?
Antibiotics clear the overgrown bacteria but do not rebuild the protective lactobacilli that keep vaginal pH low. A bacterial biofilm on the vaginal wall can also survive a standard course and reseed the imbalance. If the original trigger is still present, the same conditions return within weeks.
Does suppressive metronidazole gel work?
Twice-weekly vaginal metronidazole gel for three to six months reduces the number of recurrences while it is being used. The benefit largely stops when the gel is stopped, so it is a control strategy rather than a cure and needs prescriber supervision.
Is lactic acid gel as good as metronidazole for recurrent BV?
No. The UK VITA trial compared the two directly in women with recurrent BV and found symptom resolution at two weeks in 70% on oral metronidazole versus 47% on intravaginal lactic acid gel. Lactic acid gel is not an equivalent replacement for antibiotic treatment of an active episode.
Should my male partner be treated for BV?
This is changing. A 2025 randomised trial published in the New England Journal of Medicine found BV recurrence at 12 weeks in 35% of women whose male partner was also treated, versus 63% when only the woman was treated. UK guidance does not yet routinely recommend partner treatment, so discuss it with a prescriber rather than assuming it applies to you.
Can probiotics stop BV coming back?
The evidence is not currently strong enough to recommend probiotics as a treatment or as reliable prevention. Trials are small and inconsistent in the strains and doses used. They are unlikely to cause harm, but they should not replace treatment of a confirmed episode.
When should I be referred to a specialist for BV?
Ask for referral to a sexual health or gynaecology service if you have three or more confirmed episodes in a year, if episodes do not respond to first-line treatment, if the diagnosis is uncertain, or if you are pregnant and having repeated episodes.
Completing the treatment
If your episodes are confirmed and uncomplicated, Access Doctor can supply BV treatment following an online consultation with a pharmacist independent prescriber. Where recurrence is the issue, tell us in the consultation — the pattern changes which option is appropriate, and a vaginal preparation is often the better fit for someone who has had several oral courses.
Bacterial vaginosis · Rx
Metronidazole 400mg Tablets
First-line oral antibiotic for BV, taken twice daily for five to seven days.
View product →Bacterial vaginosis · Rx
Zidoval Vaginal Gel
Metronidazole 0.75% gel — used nightly for five nights, or twice weekly for suppression.
View product →Bacterial vaginosis · Rx
Dalacin 2% Cream
Clindamycin vaginal cream — a seven-night course with no alcohol restriction.
View product →Self-test · Pharmacy
Canestest Self-Test
Checks vaginal pH at home to help distinguish BV from thrush before you treat.
View product →References
- National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Bacterial vaginosis. 2025. cks.nice.org.uk
- Armstrong-Buisseret L, Brittain C, Hepburn T, et al. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT. NIHR Health Technology Assessment, 2022. ncbi.nlm.nih.gov
- Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine, 2025. nejm.org
- Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines: Bacterial Vaginosis. cdc.gov
- British Association for Sexual Health and HIV. National guideline for the management of vaginal discharge. bashh.org
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. In a medical emergency, call 999.